Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs12761973 | chr10:134440065 | C/T | 0.00036 | 170 | 24.62 | 26.62 | 2.23 | KM Plot |
PCPG | rs12767009 | chr10:29855290 | C/T | 4.75E-11 | 177 | 25.77 | 17.52 | 10.3 | KM Plot |
PCPG | rs12767762 | chr10:134443032 | A/G | 0.00036 | 170 | 24.62 | 26.62 | 2.23 | KM Plot |
PCPG | rs12768540 | chr10:29855377 | T/A | 4.75E-11 | 177 | 25.77 | 17.52 | 10.3 | KM Plot |
PCPG | rs12770777 | chr10:134409693 | C/T | 0.000327 | 172 | 24.85 | 25.92 | 2.23 | KM Plot |
PCPG | rs12771180 | chr10:29853891 | C/T | 6.74E-11 | 175 | 25.67 | 16.83 | 10.3 | KM Plot |
PCPG | rs12775980 | chr10:29859856 | A/C | 4.77E-7 | 178 | 7.48 | 17.77 | 25.77 | KM Plot |
PCPG | rs12782110 | chr10:134347785 | A/G | 4.09E-6 | 178 | 14.37 | 25.92 | 25.4 | KM Plot |
PCPG | rs12783213 | chr10:134402349 | G/A | 2.22E-16 | 170 | 25.08 | 28.45 | 2.23 | KM Plot |
PCPG | rs12783312 | chr10:134402543 | C/T | 0.000327 | 172 | 24.85 | 25.92 | 2.23 | KM Plot |
PCPG | rs12811020 | chr12:26890219 | C/G | 7.57E-6 | 177 | 24.5 | 28.47 | 5.97 | KM Plot |
PCPG | rs12811022 | chr12:26890222 | C/G | 7.57E-6 | 177 | 24.5 | 28.47 | 5.97 | KM Plot |
PCPG | rs12812095 | chr12:26869047 | C/T | 8.98E-5 | 177 | 24.3 | 27.87 | 5.97 | KM Plot |
PCPG | rs12813817 | chr12:26892605 | G/C | 0.000114 | 174 | 24.3 | 28.47 | 5.97 | KM Plot |
PCPG | rs12816224 | chr12:26896460 | C/T | 0.00011 | 174 | 24.5 | 27.83 | 5.97 | KM Plot |